[Current syphilis therapies and serological control. Commentary on the article by M. Hartmann in Hautarzt, Volume 2 (2004)]
- PMID: 15448930
- DOI: 10.1007/s00105-004-0834-0
[Current syphilis therapies and serological control. Commentary on the article by M. Hartmann in Hautarzt, Volume 2 (2004)]
Abstract
Penicillin is currently the drug of choice for therapy of syphilis. Clemizole and procaine penicillin are no longer available. For this reason only benzathine penicillin and infusion therapy with benzyl penicillin are possible. Treatment with doxycyline or ceftriaxone is also conceivable. Suitable serological methods are necessary to control the safety of the therapy.
Similar articles
-
[Therapy of syphilis].Hautarzt. 2004 Feb;55(2):215-6. doi: 10.1007/s00105-003-0611-5. Hautarzt. 2004. PMID: 14968333 German. No abstract available.
-
A new enhanced antibiotic treatment for early and late syphilis.J Glob Antimicrob Resist. 2016 Jun;5:64-6. doi: 10.1016/j.jgar.2015.12.006. Epub 2016 Jan 21. J Glob Antimicrob Resist. 2016. PMID: 27436469 Clinical Trial.
-
[Serodiagnosis and therapy of syphilis].Ther Umsch. 1985 Nov;42(11):773-80. Ther Umsch. 1985. PMID: 3911474 Review. German. No abstract available.
-
Early syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin.J Infect Dev Ctries. 2014 Feb 13;8(2):228-32. doi: 10.3855/jidc.3013. J Infect Dev Ctries. 2014. PMID: 24518634
-
Penicillin and the control of syphilis.Am Heart J. 1974 Oct;88(4):395-400. doi: 10.1016/0002-8703(74)90198-7. Am Heart J. 1974. PMID: 4606895 Review. No abstract available.
Cited by
-
Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells.Br J Pharmacol. 2017 Feb;174(3):254-266. doi: 10.1111/bph.13679. Epub 2017 Jan 12. Br J Pharmacol. 2017. PMID: 27886373 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical